Cristina Aparecida Troques Mitteldorf

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Leukopenia and selective CD4+ lymphopenia represent major adverse events associated with the use of temozolomide (TMZ), an oral alkylating agent incorporated in the treatment of glioblastoma (GBM). The increased risk of opportunistic infections, including those caused by Pneumocystis jiroveci and cytomegalovirus, has been previously described in the(More)
  • 1